Key facts
- This page summarizes Ann D. Rhoads's Form 4 filing for QuidelOrtho Corp (QDEL).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 23 May 2024, 18:28.
Ann D. Rhoads - 22 May 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- Director
- Issuer ticker
- QDEL
- Reported as of
- 22 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 May 2024, 18:28:20 UTC
- Prior SEC filing
- 30 Jan 2024
- Next SEC filing
- 29 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ann D. Rhoads filed Form 4 for QuidelOrtho Corp (QDEL) on 23 May 2024.
Change
- Previous filing in this sequence was filed on 30 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
transaction
Derivative
Restricted Stock Units (Equity Grant)
Award
- Transaction value
- $0
- Shares
- +4,929
- Change %
- Price
- $0.000000
- Shares after
- 4,929
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,929
- Exercise price
- Footnotes
- F1, F2
QDEL
transaction
Derivative
Restricted Stock Units (Converted)
Award
- Transaction value
- $0
- Shares
- +1,173
- Change %
- Price
- $0.000000
- Shares after
- 1,173
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,173
- Exercise price
- Footnotes
- F1, F3, F4
QDEL
transaction
Derivative
Restricted Stock Units (Premium)
Award
- Transaction value
- $0
- Shares
- +234
- Change %
- Price
- $0.000000
- Shares after
- 234
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 234
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
Footnote F2
The restricted stock units vest on May 22, 2025.
Footnote F3
The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Footnote F4
293 shares vested on May 22, 2024, 293 shares will vest on August 22, 2024, 293 shares will vest on November 22, 2024 and 294 shares will vest on February 22, 2025.